SCHEMBL545944

SCHEMBL545944

O=C(Nc1cc(OCCN2CCCC2)cc(C(F)(F)F)c1)c1ccc2ccccc2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRAF P15056 2/20 0.53
RXFP1 Q9HBX9 2/20 0.53
MCHR1 Q99705 4/20 0.52
EPHX2 P34913 1/20 0.52
KDR P35968 3/20 0.49
HTR2A P28223 2/20 0.49
HTR2C P28335 2/20 0.49
ENPP3 O14638 1/20 0.48
ENPP1 P22413 1/20 0.48
MEN1 O00255 1/20 0.48
NPC1 O15118 1/20 0.48
POLB P06746 1/20 0.48
MAPT P10636 1/20 0.48
RAB9A P51151 1/20 0.48
KMT2A Q03164 1/20 0.48
MCL1 Q07820 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
KDM4E B2RXH2 1/20 0.48
LTA4H P09960 1/20 0.47
BCHE P06276 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5426983 0.84 KDR (0.53) BRAFRXFP1MCHR1EPHX2KDR
SCHEMBL5420350 0.83 KDR (0.52) BRAFMCHR1KDRHTR2AHTR2C
SCHEMBL4969245 0.83 MCHR1 (0.70) MCHR1KDRMEN1NPC1POLB
SCHEMBL546280 0.82 KDR (0.53) BRAFKDRHTR2AHTR2CLTA4H
SCHEMBL546211 0.82 KDR (0.68) BRAFKDRHTR2AHTR2C
SCHEMBL27289490 0.82 MET (0.49) BRAFRXFP1MCHR1EPHX2KDR
SCHEMBL5438836 0.81 KDR (0.54) BRAFKDR
SCHEMBL10199786 0.80 KDR (0.51) BRAFRXFP1MCHR1EPHX2KDR
SCHEMBL27289467 0.78 BRAF (0.47) BRAFRXFP1MCHR1EPHX2KDR
SCHEMBL546100 0.78 KDR (0.49) BRAFRXFP1MCHR1KDRHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8110687-B2 Bicyclic compounds with kinase inhibitory activity MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-02-07 US disclosed